Searched for
SUN PHARMA NEWS
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...- Capitalmind Flexi Cap Fund exits Vedanta and 10 others; adds 9 stocksDeepak Shenoy-backed Capitalmind Flexi Cap Fund exited 11 stocks, including Vedanta and Vedanta Oil and Gas, and added nine stocks, includi...
- Sensex drops 326 points, Nifty closes below 23,100 as market bleeds for 7th session. What lies ahead?Indian equities extended their losing streak on Wednesday, with the Nifty 50 declining for a seventh consecutive session amid rising oil pr...
- Why did stock market fall today? Sensex slides 281 pts, Nifty closes below 24,300. 5 factors behind the declineIndian stock indices extended losses on Monday, with Sensex and Nifty declining. Broader markets bucked the trend, closing higher as crude ...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Why did market rise today? Sensex surges 540 points, Nifty tops 24,770. 6 key factors fueling Rs 5 lakh crore rallyIndian stock markets experienced a significant surge on Monday. Nifty and Sensex indices both closed higher after positive news emerged. Pr...
- Stocks in news: Maruti Suzuki, ITC, ZEE, Persistent Systems, and Muthoot FinanceMarkets extended their winning streak on Friday, supported by encouraging quarterly business updates. Nifty strengthened its bullish struct...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- Stocks in news: Maruti Suzuki, ITC, Vedanta, Swiggy, RILIndian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Will Sensex, Nifty extend gains on Monday? Q1 earnings, global tech selloff among 6 factors to steer D-St this weekDalal Street ended the week on a strong note, with the Sensex and Nifty gaining over 1% on Friday. Investors will track six key market trig...
- Stocks in news: HDFC Bank, Vedanta Power, YES Bank, Sun Pharma, Waaree EnergiesIndian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank an...
- Sensex jumps 262 points, Nifty closes above 24,270. 7 key factors behind today's D-Street gainsIndian stock markets surged on Friday, with Sensex and Nifty climbing over 0.3% each. This rally was fueled by easing Middle East tensions,...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma Q1 Results: Net profit rises 40% YoY to Rs 2,836 crore, beats estimatesSun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 cr...
- Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
- Sun Pharma Q4 Results: Firm posts surprise loss of Rs 2,277 croreThe company said during the quarter and year ended March 31, 2022 the company incurred a one-time cost of Rs 56.35 crore in relation to res...
- Sun Pharma gets 3 observations from USFDA for Halol plantThe United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol f...
Load More
